ASH 65th Annual Meeting & Exposition: Friday Satellite Symposia

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care

This program is supported by an educational grant from Genmab US, Inc. and AbbVie

3:00 p.m. - 6:00 p.m. Pacific time

San Diego Convention Center
Room 30 A-E

Access Program Details

This activity is intended to educate clinicians regarding the use and integration of new and emerging BCMA-targeted therapies in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). In the “Care Team Forum,” an expert panel will present 3 series of didactic slides, followed by discussion that will include a patient with R/R DLBCL; they will share key aspects of their therapeutic journey. Polling questions will be interspersed throughout the symposium to assess improvements in knowledge and competence among attendees.


Joshua Brody, MD
Icahn School of Medicine at Mount Sinai
New York, NY


Lorenzo Falchi, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Lori A. Leslie, MD
Hackensack Meridian School of Medicine
Hackensack, NJ

Erika Sinofsky , RMEI Medical Education, LLC